Shopping Cart 0
Cart Subtotal
AED 0

Biocept Inc (BIOC) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company's OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Biocept Inc, Medical Equipment, Deal Details 12

Partnerships 12

Biocept Enters into Marketing Agreement with Miraca Life Sciences 12

Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13

Addario Lung Cancer Medical Institute and Biocept Enter into Partnership 14

Biocept Enters into Agreement with OHSU Knight Cancer Institute 15

Biocept Enters into Agreement with Catalyst Pharma 16

Biocept Enters into Agreement with Teneovita Medical Innovations 17

Biocept Forms Partnership with MedStar Georgetown University Hospital 18

Biocept to Form Partnership with Quest Diagnostics Mexico 19

Biocept Enters into Agreement 20

Biocept Enters into Distribution Agreement with Progenetics 21

Biocept Enters into Co-Development Agreement with Baylor College of Medicine 22

Biocept and Insight Genetics Enter into Agreement 23

Biocept Enters into Partnership with Life Technologies 24

Equity Offering 25

Biocept Raise USD11.6 Million in Rights Offering of Units 25

Biocept Prices Public Offering of Shares for USD2.5 Million 27

Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants 29

Biocept Prices Public Offering of Shares for USD3.3 Million 31

Biocept Prices USD3.3 Million in Public Offering of Shares 33

Biocept Plans to Raise Funds through Private Placement of Shares 34

Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 35

Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 36

Biocept Raises USD10 Million in Public Offering of Shares and Warrants 37

Biocept Prices Public Offering of Shares and Warrants for USD5 Million 38

Biocept to Raise USD15 Million in Public Offering of Shares 39

Biocept Raises USD10 Million in Public Offering of Shares and Warrants 40

Biocept Completes IPO For USD 19 Million 42

Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 43

Biocept Inc-Key Competitors 44

Biocept Inc-Key Employees 45

Biocept Inc-Locations And Subsidiaries 46

Head Office 46

Recent Developments 47

Financial Announcements 47

Aug 14, 2018: Biocept reports second quarter 2018 financial results 47

May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 50

Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 52

Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 55

Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 58

May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 61

Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 63

Corporate Communications 65

Sep 10, 2018: Biocept names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer 65

Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board 66

Feb 15, 2017: Biocept Appoints Michael Terry Senior Vice President Commercial Operations 67

Government and Public Interest 68

Jan 30, 2018: Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer 68

Product News 69

Sep 24, 2018: Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy 69

Aug 02, 2018: Biocept awarded patent in Canada for its target selector CTC platform 70

Jul 31, 2018: European patent granted for Biocept's target selector oncogene mutation enrichment and detection platform 71

Jun 11, 2018: VWR and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs 72

Mar 20, 2018: Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit 73

Mar 15, 2018: Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting 74

Feb 05, 2018: Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform 75

Jan 04, 2018: Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources 76

Dec 05, 2017: First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform 77

Other Significant Developments 78

Jul 23, 2018: Biocept and UC San Diego Moores Cancer Center announce collaboration to study feasibility of liquid biopsy to predict disease recurrence in solid tumors and response to therapy 78

Jul 17, 2018: Alliance Global to market Biocept liquid biopsy tests 79

Mar 28, 2018: Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration 80

Dec 18, 2017: Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota 81

Oct 18, 2017: Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals 82

Aug 14, 2017: Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR 83

Aug 07, 2017: Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform 84

Jun 21, 2017: Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing 85

Jan 10, 2017: Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas 86

Appendix 87

Methodology 87

About GlobalData 87

Contact Us 87

Disclaimer 87


List Of Figure

List of Figures

Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biocept Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Biocept Inc, Medical Equipment, Key Facts, 2017 2

Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biocept Inc, Deals By Market, 2012 to YTD 2018 9

Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Biocept Enters into Marketing Agreement with Miraca Life Sciences 12

Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13

Addario Lung Cancer Medical Institute and Biocept Enter into Partnership 14

Biocept Enters into Agreement with OHSU Knight Cancer Institute 15

Biocept Enters into Agreement with Catalyst Pharma 16

Biocept Enters into Agreement with Teneovita Medical Innovations 17

Biocept Forms Partnership with MedStar Georgetown University Hospital 18

Biocept to Form Partnership with Quest Diagnostics Mexico 19

Biocept Enters into Agreement 20

Biocept Enters into Distribution Agreement with Progenetics 21

Biocept Enters into Co-Development Agreement with Baylor College of Medicine 22

Biocept and Insight Genetics Enter into Agreement 23

Biocept Enters into Partnership with Life Technologies 24

Biocept Raise USD11.6 Million in Rights Offering of Units 25

Biocept Prices Public Offering of Shares for USD2.5 Million 27

Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants 29

Biocept Prices Public Offering of Shares for USD3.3 Million 31

Biocept Prices USD3.3 Million in Public Offering of Shares 33

Biocept Plans to Raise Funds through Private Placement of Shares 34

Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 35

Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 36

Biocept Raises USD10 Million in Public Offering of Shares and Warrants 37

Biocept Prices Public Offering of Shares and Warrants for USD5 Million 38

Biocept to Raise USD15 Million in Public Offering of Shares 39

Biocept Raises USD10 Million in Public Offering of Shares and Warrants 40

Biocept Completes IPO For USD 19 Million 42

Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 43

Biocept Inc, Key Competitors 44

Biocept Inc, Key Employees 45

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Biocept Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.